News for $GBLX on the Financial Side@ GrowBLOX Sc
Post# of 18844
![Avatar](/images/ProfileImages/no_avatar_available.jpg)
GrowBLOX Sciences, Inc. Announces Insider Buying as Lazarus Investment Partners LLLP Acquires Additional Shares
2014-07-07 08:23 ET - News Release
LAS VEGAS, July 7, 2014 /PRNewswire/ -- GrowBLOX Sciences, Inc. (OTCQB: GBLX), a biotechnology and research company, today is pleased to announce that their largest investor, Lazarus Investment Partners LLLP, has acquired an additional 269,632 shares in the open market for an additional $322,000 investment. Lazarus, which already holds a 3,000,000 share investment at a price of $0.50, averaged up their position acquiring 199,632 shares at $1.19, 50,000 shares at $1.21, and 20,000 shares at $1.20 over a three day period from June 30, 2014, to July 2, 2014.
Lazarus Investment Partners LLLP increasing their investment by averaging up and acquiring additional shares in the open market shows their belief in GrowBLOX Sciences, Inc. and our ability to execute on our business plan. The move also proves that Lazarus considers shares of GrowBLOX Sciences, Inc. to be undervalued at current levels. The Company has made substantial headway in becoming a biotechnology leader in the legal cannabis space over the last few months which has given Lazarus the confidence to increase their investment at a much higher price.
GrowBLOX Sciences, Inc. is excited to have a quality and experienced investment firm like Lazarus Investment Partners LLLP so interested in the Company. We are looking forward to continued progression in the legal cannabis space and further developing our relationship with Lazarus Investment Partners LLLP.
About GrowBLOX Sciences, Inc.
GrowBLOX Sciences, Inc., is a research and biotechnical company that has developed proprietary indoor growing chambers specifically designed for medical cannabis cultivation. The GrowBLOX chamber allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product. The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing, will empower the public, nutraceutical and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions. http://www.gbsciences.com
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.